SEC Form 4 · accession 0001144204-16-093770
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas A. Penn
Director
Period of report
Apr 7, 2016
Accepted (ET)
Apr 11, 2016 · 7:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 7, 2016 | A | 1,000 | $0.00 | A | 10,110 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to PurchaseF1,F2 | $40.59 | Apr 7, 2016 | A | 2,000 | A | Apr 7, 2017 | Apr 6, 2026 | Common Stock | 2,000 | 2,000 | D |
Explanation of responses
- F1On April 7, 2016, the Board of Directors of the Issuer approved the grant of restricted stock and stock options reported herein, both of which vest on the first anniversary of the grant date.
- F2The closing price of the Issuer's common stock on The NASDAQ Global Market on the grant date.